Member Profile
Membership type: full
Lizet Sanchez Valdes
Country of origin: Cuba Currently in: Cuba, Havana General field of specialization: Mathematical sciences-
Degrees
2006 Doctorate Medical and Health Sciences incl Neurosciences2023 Doctorate Mathematical sciences -
Current Research Activities
Medical and Health Sciences incl Neurosciences
Statistical methods in early drug development and post-authorization study. Evaluation of long term survival in cancer. Identification of predictive biomarkers of therapeutic success. Modelling infectious diseases. Evaluation of public health intervention.
Publications resulting from Research:
Ortiz Carrodeguas, R. A., et al. (2024). "Safety and effectiveness of CIMAvax-EGF administered in community polyclinics." Frontiers in Oncology 13: 1287902.
De Witte, D., et al. (2023). "A multivariate spatio-temporal model for the incidence of imported COVID-19 cases and COVID-19 deaths in Cuba." Spatial and Spatio-temporal Epidemiology 45: 100588.
Sánchez, Y., et al. (2023). "Nimotuzumab Concurrent with Gemcitabine as First‐Line Treatment of Locally Advanced or Metastatic Pancreatic Adenocarcinoma." BioMed Research International 2023(1): 1496072.
Diaz, H., et al. (2022). "Nimotuzumab Increases the Recovery Rate of Severe and Critical COVID-19 Patients: Evaluation in the Real-World Scenario." Frontiers in Public Health 10: 948520.
Alonso A et al. (2022). "Identifying individual predictive factors for treatment efficacy". Biometrics. 78(1):35-45.
Más-Bermejo, P. I., et al. (2022). "Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study." The Lancet Regional Health–Americas 18:100422
Caballero, A., et al. (2020). "Treatment of COVID‐19 patients with the anti‐CD6 antibody itolizumab." Clinical & Translational Immunology 9(11): e1218.
Lorenzo-Luaces, P., et al. (2020). "Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients." BMC cancer 20: 1-8.
Sanchez, L., et al. (2018). Differential effects of two therapeutic cancer vaccines on short-and long-term survival populations among patients with advanced lung cancer. Seminars in Oncology, 45(1-2):52-57.
Sebrango-Rodríguez, C. R., et al. (2017). "Real-time parameter estimation of Zika outbreaks using model averaging." Epidemiology & Infection 145(11): 2313-2323.
Current profession
Current professional activities type:ResearchStatistical modelling applied to biomedical and health science
Workshop and Conference Attended
2023 Havana COMPUMAT2022 Havana BioHabana2021 Mexico Moving from COVID-19 Mathematical Models to Vaccine Desing: Theory, Practice and Experiences -
Other Awards
Jun 2023Award of the Cuban Academy of Sciences1-Epidemiological evaluation of risks, equity and results of vaccination in the sustainable control of COVI D-19 in Cuba. 2-Clinical and seroepidemiological surveillance of dengue in Havana. 1997-2019. 3-Repositioning of the Cuban humanized monoclonal antibody Nimotuzumab in the treatment of patients with COVID-19,Aug 2023National Award for Technological InnovationSocial impact of scientific modeling in the multidisciplinary confrontation of COVID-19 in CubaJul 2021Sofia Kovalevskaya Mathematics Prize, research categoryThe acknowledgement is sponsored by the Kovalevskaya Foundation and the Faculty of Mathematics and Computing of the University of Havana, and its purpose is to encourage women from developing countries to participate actively in the scientific and technological life of their nations.